The purpose of this study was to conduct a prospective trial evaluating the efficacy of a local anesthetic pain pump in breast reduction surgery. Ninety-eight women undergoing bilateral breast reduction were enrolled. Thirty-seven patients received a pain pump containing 0.25% bupivicaine, and 61 patients received no pain pump. Parameters measured included subjective pain, episodes of postoperative nausea and vomiting (PONV), and the amount of narcotics and antiemetics used. Patients receiving a pain pump reported significantly lower pain scores on the day of surgery, as well as on the first and second postoperative days when compared with patients who did not (P < 0.01). The amount of intravenous and oral narcotics used paralleled the reduction in pain (P < 0.01), and there were fewer episodes of PONV and antiemetics used in the patients receiving a pain pump (P < 0.01). A postoperative local anesthetic pain pump can reduce pain, narcotic use, and PONV in women undergoing breast reduction.
From the Division of Plastic and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.
Received June 20, 2007, and accepted for publication, after revision, September 3, 2007.
Supported by internal funds of the Division of Plastic Surgery at Northwestern University. The pain pumps were donated by the manufacturer, McKinley Medical, LTD (Lancashire, England). None of the authors have any financial interest in this company.
Reprints: Neil A. Fine, MD, Division of Plastic Surgery, Northwestern University Feinberg School of Medicine, 675 N. St. Clair, Suite 19-250, Chicago, IL 60611. E-mail: firstname.lastname@example.org.